XV Jornada Paulista de Urologia

Phillip Pierorazio Johns Hopkins Hospital - EUA	O Dr. Pierorazio tem experiência em todas as áreas de UroOncologia e tem grande experiência em cirurgias minimamente invasivas incluindo vídeolaparoscopia e robóticas do rim, bexiga, próstata e dissecção de linfonodos retroperitoneal para câncer de testículo. Ele tem um interesse especial no câncer de rim, incluindo a nefrectomia parcial para a doença e fase inicial e cirurgias de alto risco para pacientes em estágios avançados. Paralelamente participa de pesquisa na área de próstata de alto risco e câncer urotelial. Ele tem um especial interesse em câncer testicular e de rim.

Mariano Sebastián González Diretor Médico do Urological Institute of Buenos Aires - Argentina	Dedicado ao tratamento endourológico , bem como a resolução da doença da próstata com tecnologia de ponta.

Emmanuel Chartier-Kastler Working at Pitié-Salpétrière academic hospital (urology department) and at Pierre et Marie Curie medical school, Sorbonne Universités, Paris 6 University, Paris, France	Prof. E. Chartier-Kastler received his MD from Paris 6 University in 1989 and was accredited as a urologist in 1992. He is accredited as general surgeon and urologist. He was fellow and assistant professor between 1992 and 1998 in the department of urology of the academic Pitié-Salpétrière hospital. Since September 2001, he is professor of urology at the department of urology, medical school Pierre et Marie Curie, University Paris 6, France. He is head of the functional urology programme including female and male urinary incontinence diagnosis and management, female pelvic floor disorder, urological malformations and neurourology. His research areas include incontinence diagnosis and management (pharmacological treatment, devices and surgery), overactive bladder (neuromodulation, botulinum toxin studies and other new treatments under development), BPH (new treatments) and neurourology. Fellows from Europe or Québec are routinely working in the department taking part of the surgical activity dedicated to this field linked with the major rehabilitation centers of Paris area. [mais] Prof. Chartier-Kastler is an active member of the board of the French Association of Urology (AFU), past general secretary (2004-2007) and past chairman of the scientific committee, past member of the AFU Neurourology Committee and active member of the French speaking group of Neurourology (GENULF, past secretary general). He is involved in all major international congresses of urology as speaker, chairman and/or guest speaker. He was involved in the French consensus conference regarding urinary nosocomial infections (2004) and has been an active member of the committee for conservative treatment in the neuropathic area during the International Consultation on Incontinence (ICI) from 1998 to 2006 and the recent SIU-ICUD consultation on spinal cord injury as co-chair of a committee. Teaching activities are of great importance as part of the development and research programme in the area of functional urology. He chaired within the last 6 years the French resident’s teaching programme in this area and was also involved in the EUREP programme (2008-2012) as also active every year for ESU courses and EAU educational activities. Prof. Chartier-Kastler has published more than 320 peer-reviewed articles and book chapters on topics related to urology, especially in the field of incontinence and neuro-urology. He is leading with Pr Giuliano (chair) and Pr Denys a public research unit (INSERM U 1179) dedicated to neuropharmacology of the bladder and sexual dysfunction, so that many students are working on for master or PhD degree. His running projects concern botulinum toxin for overactive bladder and BPH, evaluation of new drugs in this area and interstitial cystitis evaluation and animal models for study of neuromodulation mecanisms of action. As a neurourologist he prepared the final report of the 2006 french congress of urology (100th congress, November 2006, Paris) : “ Neurogenic bladder and urological management” with Alain Ruffion (MD, PhD). Member of the ICS neurourology group he would like to promote knowledge and good practice in this area internationally and is the current chair of the ICS neurourology promotion committee (2014). He has been member of the organizing committee of major international meetings (ICS-IUGA 2004 and 100th SIU 2007 congress) which took place in Paris and national meetings (French congress organizer 2005, 2006 and 2007). He co-chaired the 2015 International UroGynecological Association congress in France (Nice, 2015 June 9 to 12). He is the French member of the IMC AUA. Este endereço de email está sendo protegido de spambots. Você precisa do JavaScript ativado para vê-lo. Este endereço de email está sendo protegido de spambots. Você precisa do JavaScript ativado para vê-lo.

Christian P. Pavlovich Professor of Urology and Oncology Johns Hopkins Medical Institutions Director, Urologic Oncology Johns Hopkins Bayview Medical Center Director, Urologic Oncology Fellowship	His clinical focus is on prostate, kidney and bladder cancer and benign prostatic diseases. He is experienced in performing open, laparoscopic and other minimally invasive surgeries for the management of urologic tumors, including nerve-sparing and robot-assisted laparoscopic radical prostatectomy, laparoscopic and robotic nephrectomy and partial nephrectomy, and robotic radical cystectomy. Dr. Pavlovich treats cancer with an emphasis on minimizing morbidity and maximizing quality of life, while offering patients the latest treatment options and techniques. His practice is dedicated primarily to the treatment of prostate, kidney and bladder cancer, as well as to the treatment of benign prostatic diseases. He is experienced in open, laparoscopic, and robotic minimally invasive surgery for the management of urologic tumors, including nerve-sparing laparoscopic and robot- assisted radical prostatectomy, laparoscopic and robotic nephrectomy and partial nephrectomy, and robotic radical cystectomy. A particular expertise of his is the robotic extraperitoneal (or retroperitoneal) approach to the prostate and kidney for patients with prostate or kidney cancer. This approach, which avoids entry into the abdominal cavity, is ideally suited for patients that have had prior abdominal or inguinal operations (e.g. hernia repairs, appendectomy, colectomy) or who have inflammatory conditions (e.g. Crohn’s disease, ulcerative colitis, diverticulitis) that might make an abdominal robotic approach more hazardous.

	EM BREVE MAIS NOMES A CONFIRMAR!

CONVIDADOS INTERNACIONAIS